Johanna Shulman Email

VP, Program Lead-Myelofibrosis . Karyopharm Therapeutics

Current Roles

Employees:
428
Revenue:
$118.7M
About
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. For more information, please visit www.karyopharm.com
Karyopharm Therapeutics Address
85 Wells Ave.
Newton, MA
United States
Karyopharm Therapeutics Email

Past Companies

Karyopharm Therapeutics Inc.Vice President, Program Lead-Myelofibrosis
AmgenExecutive Director, Global Commercialization Strategy, Solid Tumor Pipeline
AmgenExecutive Director, US Leukemia Sales & Marketing

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.